jcm-logo

Journal Browser

Journal Browser

Clinical Diagnosis and Management of Corneal Diseases

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".

Deadline for manuscript submissions: 10 March 2026 | Viewed by 155

Special Issue Editors


E-Mail
Guest Editor
1. Department of Ophthalmology, University Hospital of Alexandroupolis, 68100 Dragana, Alexandroupolis, Greece
2. School of Medicine, Democritus University of Thrace, 68100 Dragana, Alexandroupolis, Greece
Interests: ophthalmology; cataract; corneal diseases; presbyopia; multifocal intraocular lenses

E-Mail Website
Guest Editor
1. Department of Ophthalmology, University Hospital of Alexandroupolis, 68100 Dragana, Alexandroupolis, Greece 2. School of Medicine, Democritus University of Thrace, 68100 Dragana, Alexandroupolis, Greece
Interests: ophthalmology; cataract; corneal diseases; presbyopia; multifocal intraocular lenses; corneal transplantation; refractive surgery
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
1. Department of Ophthalmology, University Hospital of Alexandroupolis, 68100 Dragana, Alexandroupolis, Greece 2. School of Medicine, Democritus University of Thrace, 68100 Dragana, Alexandroupolis, Greece
Interests: ophthalmology; cataract; corneal diseases; presbyopia; multifocal intraocular lenses; glaucoma

Special Issue Information

Dear Colleagues,

Significant progress has been made in the diagnosis and treatment of corneal diseases. Advanced imaging techniques, such as high-resolution anterior segment OCT, corneal topography, tomography, and in vivo confocal microscopy, now enable earlier and more accurate detection of conditions including keratoconus, corneal dystrophies, trauma, infectious keratitis, and drug-induced toxicity. The integration of artificial intelligence and biomechanical analysis has further improved diagnostic precision and risk assessment. In terms of treatment, developments in medical, surgical, and regenerative approaches—from targeted antimicrobial treatments to lamellar keratoplasty and cell-based therapies—have expanded options for managing complex cases. Innovations in corneal cross-linking and tissue engineering also offer new opportunities for restoring corneal health. In this Special Issue, we welcome authors to submit papers on emerging diagnostic tools, clinical innovations, and novel therapies in the management of corneal diseases.

Dr. Eirini-Kanella Panagiotopoulou
Dr. Georgios Labiris
Dr. Panagiota Ntonti
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • corneal imaging
  • corneal disease diagnosis
  • corneal therapeutics
  • regenerative corneal treatments
  • artificial intelligence in corneal diagnostics
  • corneal cross-linking
  • lamellar keratoplasty

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

10 pages, 1060 KB  
Article
Cross-Linked Carboxymethyl Cellulose and Silk Proteins in Corneal Re-Epithelialization: A Case Series
by Francesco Boselli, Fabio Scarinci and Romina Fasciani
J. Clin. Med. 2025, 14(18), 6600; https://doi.org/10.3390/jcm14186600 - 19 Sep 2025
Viewed by 97
Abstract
Background/Objectives: Corneal re-epithelialization is a critical process following surgical procedures such as photorefractive keratectomy (PRK), phototherapeutic keratectomy (PTK), and corneal UV cross-linking (CXL), as well as cases of corneal abrasion. Delayed epithelial healing can lead to increased discomfort, a higher risk of infection, [...] Read more.
Background/Objectives: Corneal re-epithelialization is a critical process following surgical procedures such as photorefractive keratectomy (PRK), phototherapeutic keratectomy (PTK), and corneal UV cross-linking (CXL), as well as cases of corneal abrasion. Delayed epithelial healing can lead to increased discomfort, a higher risk of infection, and suboptimal visual outcomes. This retrospective case series aims to evaluate the efficacy of a novel ophthalmic solution containing cross-linked carboxymethyl cellulose (CX-CMC) and silk proteins in promoting corneal re-epithelialization and improving post-surgical recovery. Patients and methods: A total of 15 patients who underwent PRK, PTK, or CXL or who presented with corneal abrasions were included in the study. Along with standard post-surgical treatment, patients received CX-CMC and silk protein-based eye drops (CORDEV, Ophtagon, Rome, Italy) six times a day. Corneal epithelial thickness was assessed using topography at follow-up visits. Results: Corneal re-epithelialization was observed in all subjects within 24 to 48 h post-procedure. The mean corneal epithelial thickness at 48 h was 73.21 µm, which falls within the typical range of a proliferating corneal epithelium. Conclusions: The CX-CMC and silk protein-based formulation accelerated corneal healing, achieving rapid epithelial recovery. This novel ophthalmic solution offers a promising alternative to conventional post-surgical treatments, potentially improving patient outcomes by reducing healing time, minimising discomfort, and lowering the risk of complications associated with delayed re-epithelialization. Full article
(This article belongs to the Special Issue Clinical Diagnosis and Management of Corneal Diseases)
Show Figures

Figure 1

Back to TopTop